SEC Form D · filed January 22, 2024
Intrommune Therapeutics, Inc
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (15)
Hemanshu Pandya · NEW YORK, NYDirectorErick Berglund · NEW YORK, NYDirectorWilliam Reisacher · NEW YORK, NYDirectorMichael Nelson · NEW YORK, NYExec · DirectorJonathan Rich · NEW YORK, NYDirectorJonathan Rich · NEW YORK, NYDirectorErick Berglund · NEW YORK, NYDirectorMichael Nelson · NEW YORK, NYExec · DirectorHemanshu Pandya · NEW YORK, NYDirectorWilliam Reisacher · NEW YORK, NYDirectorDavid N. Aspell · Newtown, PADirectorTimothy J. Rudderow Sr · Newtown, PADirectorGerald L. Prior Iii · Newtown, PAExec · DirectorMark Russell · Spokane, WADirectorMichelle Carbon · Spokane, WADirector Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗